0
Want this question answered?
Be notified when an answer is posted
Add your answer:
Earn +20 pts
How do you use prostate in a sentence?
*(The "prostate gland" is a exocrine gland of male humans and animals. This should not be confused with the similar word "prostrate" which means lying down on the ground.)"Many older men have an enlarged prostate, and this can be a troublesome condition.""There are many new treatments for prostate cancer besides traditional surgery."
How much does a PSA test cost?
A PSA test will cost as much as $500 for those that do not have insurance. This is a test that has to do with prostate cancer in men.
Is IQ herditary?
"no"Actually there is a hereditary aspect to IQ. Researchers argue that we inherit a range of potential IQ scores, and our environment determins where in this bandwidth our score will ultimately lie.
What is genetic a factor?
two genetic materials
What genetic change is always a result of evolution?
Evolution is not a cause of genetic change: it is the effect of genetic change.
What kind of genetic tests are available for prostate cancer?
There are no genetic tests to see if you have prostate cancer. It is possible to find out by going to a doctor and having other tests done, however.
How is prostate cancer passed on?
There is a genetic risk factor. Men whos fathers had prostate cancer are at a greater risk of getting it themselves.
How does heredity figure into the incidence of prostate cancer?
Heredity plays a significant role in the incidence of prostate cancer, with genetic factors accounting for a substantial portion of the risk. Several key points illustrate how heredity figures into the incidence of prostate cancer: Family History: Men with a family history of prostate cancer, particularly those with a first-degree relative (father, brother) who has been diagnosed with the disease, have an increased risk of developing prostate cancer themselves. Studies have shown that having a father or brother with prostate cancer more than doubles a man's risk of developing the disease compared to men with no family history. Genetic Predisposition: Inherited genetic mutations or variations can contribute to an increased risk of prostate cancer. Certain genetic factors, such as mutations in the BRCA1 and BRCA2 genes, which are also associated with hereditary breast and ovarian cancer, have been linked to an elevated risk of prostate cancer in men. Additionally, other genetic variations, including single nucleotide polymorphisms (SNPs), have been identified through genome-wide association studies (GWAS) as contributing to prostate cancer susceptibility. Ethnicity: Prostate cancer incidence varies by ethnicity, with African American men having the highest risk of developing the disease. African American men are not only more likely to be diagnosed with prostate cancer but also more likely to develop aggressive forms of the disease and have poorer outcomes compared to men of other racial and ethnic groups. Genetic factors are believed to contribute to these disparities, although environmental and socioeconomic factors may also play a role. Familial Clustering: Studies have shown that prostate cancer tends to cluster within families, suggesting that shared genetic factors contribute to the disease's familial aggregation. Familial clustering of prostate cancer may reflect a combination of genetic susceptibility and shared environmental or lifestyle factors within families. Overall, hereditary factors significantly influence the incidence of prostate cancer, with family history, genetic predisposition, ethnicity, and familial clustering all playing important roles. Understanding these genetic factors is crucial for identifying individuals at higher risk of prostate cancer and implementing targeted screening, prevention, and early detection strategies. Additionally, ongoing research efforts aimed at elucidating the genetic mechanisms underlying prostate cancer susceptibility may lead to improved risk stratification and personalized approaches to prostate cancer prevention and management.
Is prostate cancer an infectious disease?
Prostate cancer is not considered an infectious disease. Unlike infections caused by bacteria, viruses, or other pathogens that can be transmitted from person to person, prostate cancer is a type of cancer that develops within the prostate gland due to the uncontrolled growth of abnormal cells. While infectious agents such as viruses or bacteria have been implicated in the development of some cancers, there is currently no strong evidence to suggest that prostate cancer is caused by an infectious agent. The majority of prostate cancers are thought to result from a combination of genetic, environmental, and lifestyle factors, rather than infectious causes. However, certain infections and inflammation of the prostate gland, such as chronic prostatitis or sexually transmitted infections, may be associated with an increased risk of developing prostate cancer in some cases. Chronic inflammation in the prostate gland has been hypothesized to contribute to the development and progression of prostate cancer, although the exact mechanisms are not fully understood. Overall, while infections and inflammation may play a role in some cases, prostate cancer is primarily considered a non-infectious disease driven by genetic, hormonal, and environmental factors. Early detection through regular screening and consultation with a healthcare professional remain critical for managing prostate cancer risk and detecting the disease in its early stages.
Where did prostate cancer originate from?
Prostate cancer originates in the prostate gland, which is a part of the male reproductive system. The prostate gland is a small, walnut-sized organ located just below the bladder and in front of the rectum. It produces seminal fluid, a fluid that nourishes and transports sperm. Prostate cancer typically begins in the cells of the prostate gland, specifically in the glandular cells, which are responsible for producing seminal fluid. As these cancerous cells multiply and grow, they can form tumors within the prostate. In its early stages, prostate cancer often remains confined to the prostate gland and may not cause noticeable symptoms. The exact cause of prostate cancer is not fully understood, but it is believed to be influenced by a combination of genetic, environmental, and hormonal factors. Age, family history, and ethnicity can also play a role in the development of prostate cancer. Regular screening and early detection through methods like the prostate-specific antigen (PSA) blood test and digital rectal examination (DRE) are important for identifying prostate cancer in its early, more treatable stages.
How can one participate in prostate cancer research?
There are a number of references where one can get information about participating in prostate cancer research. For instance, ones medical specialist may have connections to researchers involved in these studies. One may also refer to the UK Genetic Prostate Cancer or to the Prostate Cancer Research for more specific information about volunteering to be a research subject.
What factors contribute to prostate cancer, or is it random?
Prostate cancer like most cancers is mostly genetic. Also a bad health life such as not enough vitamins can also lead to this devastating disease.
Do hereditary factors increase the likelihood of contracting prostate cancer?
[From Genetics of Prostate Cancer part of the National Cancer Institute website] As with breast and colon cancer, familial clustering of prostate cancer has been reported frequently. From 5% to 10% of prostate cancer cases are believed to be due primarily to high-risk inherited genetic factors or prostate cancer susceptibility genes. Results from several large case-control studies and cohort studies representing various populations suggest that family history is a major risk factor in prostate cancer. A family history of a brother or father with prostate cancer increases the risk of prostate cancer by 2-fold to 3-fold, and the risk is inversely related to the age of the affected relative.
What is the difference between deaths from lung cancer and deaths from prostate cancer?
lung cancer is in the lungs, prostate cancer is in the prostate.
Name a risk to the male body involving the prostate gland?
One significant risk to the male body involving the prostate gland is the development of prostate cancer. Prostate cancer occurs when abnormal cells in the prostate gland grow uncontrollably, forming a tumor. It is one of the most common cancers in men, particularly in older adults. Risk factors for prostate cancer include: Age: The risk of prostate cancer increases with age, with the majority of cases diagnosed in men over 50 years old. Family history: Men with a family history of prostate cancer, especially with a father or brother, have an increased risk of developing the disease. Ethnicity: African American men have a higher risk of prostate cancer compared to men of other ethnicities. Genetic factors: Certain genetic mutations and variations may increase the risk of prostate cancer. Lifestyle factors: Poor diet, lack of exercise, obesity, and smoking may also contribute to an increased risk of prostate cancer. Regular screening for prostate cancer, including prostate-specific antigen (PSA) blood tests and digital rectal exams (DREs), can help detect the disease in its early stages when treatment is most effective. It's essential for men to discuss the benefits and risks of prostate cancer screening with their healthcare provider, particularly if they have risk factors for the disease. Early detection and treatment can significantly improve outcomes for individuals diagnosed with prostate cancer.
What is caused by prostate cancer?
Prostate Cancer is mostly a genetic disease. It tends to travel in families. There is no specific thing that a man can do to cause the cancer to appear. It is the biggest form of cancer in men over 50 years of age, and if not treated early enough, will certainly cause death.
What has the author Malcolm Christopher Crundwell written?
Malcolm Christopher Crundwell has written: 'Genetic alterations in early prostate cancer'
